project id: TCGA-KIRP; case submitter id: TCGA-B1-A655; source center: 23; state: released; a260 a280 ratio: 2.12; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.69; rna integrity number: 8.9; age at index: 77; days to birth: -28433; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 28433; ajcc clinical m: M0; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 510.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 420; initial weight: 80.0; sample id: 57cfc258-5350-498f-b98f-5e503ec3f683; sample submitter id: TCGA-B1-A655-01A; portion id: d201c434-4866-4176-8628-d021817675c9; portion submitter id: TCGA-B1-A655-01A-11; slide id: 8017cae1-53c2-4032-bcdb-4a23bcce8c40; slide submitter id: TCGA-B1-A655-01A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 20.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 80.0; section location: TOP;